Search Results
Results found for "Ed Brennan"
Posts (4)
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
June 2022 "We’re delighted to welcome Dr Ed Brennan as our new Vice President, Head of Clinical Development Dr Brennan has extensive experience across all phases of clinical development, and across multiple therapeutic
- Conjugation Strategies for Probe Development
K., Eds.; Elsevier, 2023; Vol. 103, pp 59–103. https://doi.org/10.1016/bs.coac.2023.02.005 .
- 📰 GPCR Weekly News, May 27 to June 2, 2024
GPCR contributor article Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan
Other Pages (2)
- Ep 51 with Dr. Mark Connor
University of Sydney (opioids and sensory neurons), Vollum Institute Portland (visiting scientist with Ed
- Ep 120 with Brendan Wilkins
GPCR Podcast << Back to podcast list Strategic Partners Brendan Wilkins About Brendan Wilkins "Brendan In his Honours year, Brendan explored small molecule allosteric modulators of the β2-adrenoceptor under Since then, Brendan worked as a research assistant at the Victor Chang Cardiac Research Institute where Brendan’s PhD project focuses on the orphan GPCR GPR146. Brendan is currently looking for post-doctoral positions to begin in mid-2024" Brendan Wilkins on the
